| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Arvee Laboratories (India) Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹189.58 |
| 52 Week High | ₹315.00 |
| 52 Week Low | ₹104.00 |
| Beta | 0.53 |
| 11 Month Change | 2.90% |
| 3 Month Change | -0.51% |
| 1 Year Change | 69.27% |
| 33 Year Change | 97.27% |
| 5 Year Change | 589.38% |
| Change since IPO | 506.66% |
Recent News & Updates
Recent updates
Here's Why We Think Arvee Laboratories (India) (NSE:ARVEE) Might Deserve Your Attention Today
Aug 08
Here's Why We Think Arvee Laboratories (India) (NSE:ARVEE) Is Well Worth Watching
Apr 13Do Arvee Laboratories (India)'s (NSE:ARVEE) Earnings Warrant Your Attention?
Dec 22We Ran A Stock Scan For Earnings Growth And Arvee Laboratories (India) (NSE:ARVEE) Passed With Ease
Sep 16Subdued Growth No Barrier To Arvee Laboratories (India) Ltd.'s (NSE:ARVEE) Price
Aug 13Calculating The Intrinsic Value Of Arvee Laboratories (India) Ltd. (NSE:ARVEE)
Apr 19Shareholder Returns
| ARVEE | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | 9.3% | -2.6% | -1.1% |
| 1Y | 69.3% | 23.1% | 40.9% |
Return vs Industry: ARVEE exceeded the Indian Chemicals industry which returned 24.3% over the past year.
Return vs Market: ARVEE exceeded the Indian Market which returned 41.6% over the past year.
Price Volatility
| ARVEE volatility | |
|---|---|
| ARVEE Average Weekly Movement | 6.0% |
| Chemicals Industry Average Movement | 6.5% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in IN Market | 9.6% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: ARVEE has not had significant price volatility in the past 3 months.
Volatility Over Time: ARVEE's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 67 | Shalin Patel | arveelabs.com |
Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company provides polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also offers drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4–amino pyridine, and 2–chloro–5–nitrobenzoic acid.
Arvee Laboratories (India) Ltd. Fundamentals Summary
| ARVEE fundamental statistics | |
|---|---|
| Market cap | ₹2.09b |
| Earnings (TTM) | ₹15.07m |
| Revenue (TTM) | ₹333.68m |
138.7x
P/E Ratio6.3x
P/S RatioIs ARVEE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ARVEE income statement (TTM) | |
|---|---|
| Revenue | ₹333.68m |
| Cost of Revenue | ₹173.75m |
| Gross Profit | ₹159.93m |
| Other Expenses | ₹144.86m |
| Earnings | ₹15.07m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.37 |
| Gross Margin | 47.93% |
| Net Profit Margin | 4.51% |
| Debt/Equity Ratio | 3.4% |
How did ARVEE perform over the long term?
See historical performance and comparison